10don MSN
Over the past decade, early-stage drug innovation has shifted toward China, researchers find
Early-stage drug development worldwide has nearly doubled over the past decade and shifted from a U.S.-dominated model to a ...
The recent uptick in IPOs is an encouraging signal after a drought for much of 2025. Experts point to AI as a driving force ...
Company expands strategic focus into one of oncology’s most urgent supportive-care challengesJericho, New York, April 02, 2026 (GLOBE NEWSWIRE) ...
April 1 (Reuters) - The weight-loss drug market is surging, with biotech firms racing to win share in a sector dominated by Novo Nordisk and Eli Lilly. Analysts forecast the industry will generate ...
Overcoming common challenges with today’s biologics, such as developing devices for high-concentration subcutaneous ...
Dec 11 (Reuters) - AnaptysBio (ANAB.O), opens new tab will end the development of its experimental drug to treat eczema as the treatment failed to meet the goals of a mid-stage trial, the company said ...
Moving a potential therapy from the laboratory to the pharmacy has always been a slow, incremental journey. “Drug development is a multi-stage process,” says Nichola McCann, associate principal ...
NorthSea Therapeutics B.V. (“NorthSea” or the “Company”), a private, late-stage clinical biotechnology company leveraging its proprietary structurally engineered fatty acids (SEFAs) platform to ...
Incyte’s experimental skin disease drug, povorcitinib, shows promise in late-stage trials, providing long-term symptom relief for hidradenitis suppurativa. Insilico Medicine partners with Eli Lilly on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results